China’s Other Global Chokehold: Pharmaceuticals

0
55

Commentary

In the on-again, off-again trade war between China and the United States, Beijing has used its near-monopoly on rare-earth elements to great effect. Threats to cut off global supplies so critical to most technologies have given President Donald Trump pause and got him to significantly moderate his tariff policies.

Beijing has another card to play. It controls enough of the global pharmaceutical supply to create shortages in the United States and elsewhere.

So far, China’s leadership has held off on playing this card or even mentioning it, probably because of the humanitarian implications of such a supply cutoff. But the threat is implicit. After all, shortfalls in Chinese exports of medical supplies during the COVID-19 pandemic demonstrated the global importance of Chinese sources.

Pressed by an overly aggressive Washington, there can be little doubt that Beijing would…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here